Journal of Clinical Endocrinology & Metabolism, Vol 80, 864-868, Copyright © 1995 by Endocrine Society

ARTICLES

Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment

M Bonde, P Qvist, C Fledelius, BJ Riis and C Christiansen
Osteometer A/S, Rodovre, Denmark.

An enzyme-linked immunosorbent immunoassay (ELISA) for a new marker of bone resorption (CrossLaps) was evaluated. The ELISA procedure determines degradation products of type I collagen in urine. Values obtained in the ELISA and in pyridinoline by high pressure liquid chromatography were correlated after a correction for creatinine. A high correlation was found (r = 0.77; n = 81). A group of postmenopausal women (n = 180) showed an increase of more than 70% compared to values in premenopausal women (n = 104). Hydroxyproline was increased by 23%, osteocalcin by 52%, pyridinoline by 31%, and deoxypyridinoline by 50%. A highly significant decrease (60.7%) in the CrossLaps values was seen after 12 months in samples from patients receiving hormone replacement therapy compared to a placebo group. The spontaneous bone loss in an untreated group of women was determined by repeated forearm bone mass measurement over 24 months. Baseline values obtained in the CrossLaps ELISA were correlated to the rate of loss, yielding a highly significant r value of -0.61, indicating that CrossLaps might be a useful parameter for assessment of the risk of osteoporosis in postmenopausal women.

This article has been cited by other articles:

				B. Galusca, M. Zouch, N. Germain, C. Bossu, D. Frere, F. Lang, M.-H. Lafage-Proust, T. Thomas, L. Vico, and B. Estour Constitutional Thinness: Unusual Human Phenotype of Low Bone Quality J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 110 - 117. [Abstract] [Full Text] [PDF]

				Y. Maeno, M. Inaba, S. Okuno, T. Yamakawa, E. Ishimura, and Y. Nishizawa Serum Concentrations of Cross-Linked N-Telopeptides of Type I Collagen: New Marker for Bone Resorption in Hemodialysis Patients Clin. Chem., December 1, 2005; 51(12): 2312 - 2317. [Abstract] [Full Text] [PDF]

				Y. Miura, M. Miura, S. Gronthos, M. R. Allen, C. Cao, T. E. Uveges, Y. Bi, D. Ehirchiou, A. Kortesidis, S. Shi, et al. Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis PNAS, September 27, 2005; 102(39): 14022 - 14027. [Abstract] [Full Text] [PDF]

				V. Parikka, P. Lehenkari, M.-L. Sassi, J. Halleen, J. Risteli, P. Harkonen, and H. K. Vaananen Estrogen Reduces the Depth of Resorption Pits by Disturbing the Organic Bone Matrix Degradation Activity of Mature Osteoclasts Endocrinology, December 1, 2001; 142(12): 5371 - 5378. [Abstract] [Full Text] [PDF]

				P. Alexandersen, A. Toussaint, C. Christiansen, J.-P. Devogelaer, C. Roux, J. Fechtenbaum, C. Gennari, J. Y. Reginster, and for the Ipriflavone Multicenter European Fracture Ipriflavone in the Treatment of Postmenopausal Osteoporosis: A Randomized Controlled Trial JAMA, March 21, 2001; 285(11): 1482 - 1488. [Abstract] [Full Text] [PDF]

				A. Caillot-Augusseau, L. Vico, M. Heer, D. Voroviev, J.-C. Souberbielle, A. Zitterman, C. Alexandre, and M.-H. Lafage-Proust Space Flight Is Associated with Rapid Decreases of Undercarboxylated Osteocalcin and Increases of Markers of Bone Resorption without Changes in Their Circadian Variation: Observations in Two Cosmonauts Clin. Chem., August 1, 2000; 46(8): 1136 - 1143. [Abstract] [Full Text] [PDF]

				N. H. Bjarnason and C. Christiansen The Influence of Thinness and Smoking on Bone Loss and Response to Hormone Replacement Therapy in Early Postmenopausal Women J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 590 - 596. [Abstract] [Full Text]

				Y. R. Nakasato, A. J. Janckila, J. M. Halleen, H. K. Vaananen, S. P. Walton, and L. T. Yam Clinical Significance of Immunoassays for Type-5 Tartrate-resistant Acid Phosphatase Clin. Chem., December 1, 1999; 45(12): 2150 - 2157. [Abstract] [Full Text] [PDF]

				P. Alexandersen, B. J. Riis, and C. Christiansen Monofluorophosphate Combined with Hormone Replacement Therapy Induces a Synergistic Effect on Bone Mass by Dissociating Bone Formation and Resorption in Postmenopausal Women: A Randomized Study J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3013 - 3020. [Abstract] [Full Text]

				N. B. Watts Clinical Utility of Biochemical Markers of Bone Remodeling Clin. Chem., August 1, 1999; 45(8): 1359 - 1368. [Abstract] [Full Text] [PDF]

				M. L. Traba, J. A. Calero, C. Mendez-Davila, C. Garcia-Moreno, and C. de la Piedra Different Behaviors of Serum and Urinary CrossLaps ELISA in the Assessment of Bone Resorption in Healthy Girls Clin. Chem., May 1, 1999; 45(5): 682 - 683. [Full Text] [PDF]

				C. Rosenquist, C. Fledelius, S. Christgau, B. J. Pedersen, M. Bonde, P. Qvist, and C. Christiansen Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen Clin. Chem., November 1, 1998; 44(11): 2281 - 2289. [Abstract] [Full Text] [PDF]

				S. Christgau, C. Rosenquist, P. Alexandersen, N. H. Bjarnason, P. Ravn, C. Fledelius, C. Herling, P. Qvist, and C. Christiansen Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides Clin. Chem., November 1, 1998; 44(11): 2290 - 2300. [Abstract] [Full Text] [PDF]

				S. Kamel, P. Fardellone, B. Meddah, F. Lorget-Gondelmann, J. L. Sebert, and M. Brazier Response of several markers of bone collagen degradation to calcium supplementation in postmenopausal women with low calcium intake Clin. Chem., July 1, 1998; 44(7): 1437 - 1442. [Abstract] [Full Text] [PDF]

				A. Caillot-Augusseau, M.-H. Lafage-Proust, C. Soler, J. Pernod, F. Dubois, and C. Alexandre Bone formation and resorption biological markers in cosmonauts during and after a 180-day space flight (Euromir 95) Clin. Chem., March 1, 1998; 44(3): 578 - 585. [Abstract] [Full Text] [PDF]

				P. J. Meunier, E. Confavreux, I. Tupinon, C. Hardouin, P. D. Delmas, and R. Balena Prevention of Early Postmenopausal Bone Loss with Cyclical Etidronate Therapy (A Double-Blind, Placebo-Controlled Study and 1-Year Follow-Up) J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2784 - 2791. [Abstract] [Full Text] [PDF]

				C. Fledelius, A. H. Johnsen, P. A.C. Cloos, M. Bonde, and P. Qvist Characterization of Urinary Degradation Products Derived from Type I Collagen. IDENTIFICATION OF A beta -ISOMERIZED ASP-GLY SEQUENCE WITHIN THE C-TERMINAL TELOPEPTIDE (alpha 1) REGION J. Biol. Chem., April 11, 1997; 272(15): 9755 - 9763. [Abstract] [Full Text] [PDF]